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Original article

Extended preservation of non-heart-beating donor livers with
normothermic machine perfusion
S. D. St Peter, C. J. Imber, I. Lopez, D. Hughes and P. J. Friend
Nuf®eld Department of Surgery, Oxford University, John Radcliffe Hospital, Oxford OX3 9DU, UK
Correspondence to: Professor P. J. Friend (e-mail: peter.friend@surgery.ox.ac.uk)

Background Non-heart-beating donor (NHBD) livers represent an important organ pool, but are
seldom utilized clinically and require rapid retrieval and implantation. Experimental work with
oxygenated perfusion during preservation has shown promising results by recovering function in these
livers. This study compared sanguinous perfusion with cold storage for extended preservation of the
NHBD liver in a porcine model.
Methods: Porcine livers were subjected to 60 min of in vivo total warm ischaemia before ¯ushing, after
which they were preserved by one of two methods: group 1 (n = 4), University of Wisconsin (UW)
solution by standard cold storage for 24 h; group 2 (n = 4), oxygenated autologous blood perfusion on
an extracorporeal circuit for 24 h. All livers were subsequently tested on the circuit during a 24-h
reperfusion phase.
Results: Livers in group 1 showed no evidence of viability during the reperfusion phase with no bile
production or glucose utilization; they also displayed massive necrosis. Livers in group 2 demonstrated
recovery of function by synthetic function, substrate utilization and perfusion haemodynamics; these
livers displayed less cellular injury by hepatocellular enzymes. All differences in parameters between the
two groups were statistically signi®cant (P < 0´05). These ®ndings were supported by histological
examination.
Conclusion: Warm ischaemia for 1 h and simple cold storage (UW solution) for 24 h renders the liver
non-viable. Oxygenated, sanguinous perfusion as a method of preservation recovers liver function to a
viable level after 24 h of preservation.

Presented to a meeting of the Association of Surgeons, Birmingham, UK, 25±27 April 2001, and published in abstract
form as Br J Surg 2001; 88(Suppl 1): 36±7
Paper accepted 12 December 2001

Introduction

Non-heart-beating donor (NHBD) livers represent a
potential pool of organs that could signi®cantly reduce
the large discrepancy between supply and demand for liver
transplantation1. The current method of preserving livers
by simple cold storage subjects the organ to a further period
of ischaemia, increasing the level of injury, and usually
leaving the organ un®t for transplantation2. The coldstored NHBD organ undergoes injury at four consecutive
stages: (1) prior to retrieval (warm ischaemia), (2) during
cold storage ischaemia, (3) during ischaemic rewarming
(warm ischaemia) and (4) at reperfusion. Consequently,
clinical experience with the NHBD liver has been
limited3±5. When cardiac arrest occurs outside the
ã 2002 Blackwell Science Ltd
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operating room, there is a high rate of primary nonfunction4. It is for these reasons that the NHBD liver is
rarely used; however, in view of the excess of demand over
supply in liver transplantation, and the lack of any
alternative means of providing long-term support to
patients with liver failure, it is important to develop
methods that make use of NHBD livers.
The use of NHBD donor livers that have experienced
substantial injury from warm ischaemia during the period of
arrest would require the capability of ameliorating the
ischaemic cellular changes either before or during the
preservation period. It was hypothesized that perfusing
the liver with an oxygenated perfusate supplemented with
nutritional support at body temperature during the
preservation period might be a way of accomplishing this
British Journal of Surgery 2002, 89, 609±616
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goal. By these means, depleted cellular substrates could be
restored during preservation, allowing the organ to tolerate
the warm ischaemic period of surgical anastomosis and
reperfusion.
This study investigated the use of oxygenated, normothermic perfusion of NHBD livers during the preservation period as an alternative to cold storage. Preservation by
normothermic blood perfusion was compared directly with
simple cold storage in the porcine model after 60 min of
warm ischaemia.
Methods

into the aorta and allowed to circulate, a 10-Fr cannula
(Medtronic, Watford, UK) was placed into the abdominal
aorta and 4 units blood were taken. Cardiac arrest was then
induced by intracardiac injection with 10 ml potassium
chloride. A period of circulatory arrest of exactly 60 min
was observed in every case before ¯ushing the liver with
3 litres cold Eurocollins solution (Soltranâ; Baxter,
Compton, UK). The livers were then assigned to a
preservation period of either simple cold storage in
University of Wisconsin (UW) solution (Viaspanâ; Du
Pont, Stevenage, UK) or machine perfusion according to
the experimental design outlined below.

Operation

Experimental design (Fig. 1)

White Landrace pigs (40 kg) were premedicated intramuscularly with ketamine (Ketasetâ; IDIS, Surbiton, UK)
10 mg/kg and midazolam (Hypnovelâ; Roche, Welwyn
Garden City, UK) 1 mg/kg. General anaesthesia was
induced with propofol (Diprivanâ; AstraZeneca, King's
Langley, UK) 0´5 mg/kg given intravenously, and maintained by an intravenous infusion of propofol (1 mg per kg
per h) together with halothane inhalation via an extended
endotracheal tube.
Upon laparotomy the porta hepatis was dissected to
delineate the anatomy. The common bile duct was ligated
and divided. The infrahepatic vena cava, portal vein
and arterial anatomy were each identi®ed. After
20 000 units of standard human heparin (Multiparinâ; CP
Pharmaceuticals, Wrexham, UK) had been injected directly

The livers were the preserved for 24 h in one of two groups:
group 1 (n = 4) ± ¯ushed and preserved in cold storage for
24 h in UW solution; group 2 (n = 4) ± placed on an isolated
perfusion circuit with whole blood at 38°C.

Group 1

Reperfusion period
All livers were tested for function after the preservation
period by using an extracorporeal circuit to perfuse the
livers with whole blood at body temperature as a surrogate
for transplantation. To replicate surgical anastomosis, both
groups were ¯ushed after preservation with 2 litres nonoxygenated cold Eurocollins solution and left for 45 min
before being ¯ushed with a warm plasma substitute
(Gelofusineâ; B. Braun, Shef®eld, UK) and reperfused on

Group 2

40-kg pigs: (1) Exsanguinated (4 units)

Arrest

(2) Intracardiac potassium
chloride injection

In vivo flush with cold EC solution after
exactly 60 min of arrest and
harvest completed

Standard flush and cold
storage in UW solution
for 24 h

Sanguinous, oxygenated perfusion
with autologous blood at 38°C on
extracorporeal circuit for 24 h

Retrieval

Preservation

45-min cold flush
Reperfusion on extracorporeal circuit
with autologous blood for 24 h to
assess function

Reperfusion

Fig. 1 Experimental design. EC, Eurocollins; UW, University of Wisconsin
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the extracorporeal circuit. The blood used to perfuse livers
in group 2 was changed between the preservation and
reperfusion phases so that a fair comparison of physiological
parameters could be made.

was measured at 12 and 24 h of reperfusion. At the end of
each perfusion, the liver was sectioned and multiple random
samples were assessed histologically for evaluation of
reperfusion injury.

Assessment of function

Perfusion circuit

Arterial blood gases, venous blood gases, blood glucose,
haemodynamics and bile production were also documented
every hour of the reperfusion phase. Perfusate was sampled
every hour for the ®rst 8 h of the reperfusion period and
every 4 h thereafter for conventional liver function testing
and estimation of urea and electrolyte levels.
Full blood count and factor V samples were taken every
2 h for the ®rst 8 h, and then every 4 h. Galactose clearance

The circuit consisted of an oxygenator (1500 ECMO
Oxygenator; Medtronic), a heat exchanger (Ecmotherm
II HE; Medtronic), a centrifugal pump (BP50 Centrifugal
Pump; Medtronic), an 800-ml venous reservoir bag
(Medtronic) and polyvinylchloride tubing (Medtronic)
with an internal diameter of 1/4 and 3/16 inches (Fig. 2).
During priming, the perfusion circuit was supplemented
with 9´2 mmol calcium chloride, 20 mmol sodium bicar-

Soft-shell
reservoir

Prostacyclin

Heparin

Flow
probe
IMED

Heat
exchanger

q3 ≈ 1·5 l/min

FP

Hepatic portal vein

q2 ≈ 0·3 l/min

Ppv ≈ 5–10 mmHg

Hepatic artery

Pha ≈ 85–95 mmHg
q1 ≈ 1·8 l/min

Inferior vena cava

Pivc ≈ 0–3 mmHg
P1

Isolated
pig's liver
Bile

FP
Oxygenator

Centrifugal
pump

Ascites
lines

Fig. 2 Extracorporeal perfusion circuit. FP, ¯ow probe; IMED, infusion pump; P, pressure, q, ¯ow; ivc, inferior vena cava; ha, hepatic
artery; pv, portal vein
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bonate and 7000 units heparin in all cases. Temperature
was maintained at 38°C. The circuit was supplemented with
a continuous infusion of prostacyclin (Flolanâ; Glaxo
Wellcome, Uxbridge, UK) at 4 ml/h, 2 per cent taurocholic
acid (Sigma, Watford, UK) at 7 ml/h and nutrition
(Nutri¯exâ; B. Braun) at 17 ml/h. Nutrition consisted of
96 g amino acids and 300 g anhydrous glucose in 2 litres of
solution, while fats were excluded. Regular human insulin
(Humulinâ; CP Pharmaceuticals), 100 units, was added to
each bag. Heparin, 3000 units, was added every 4 h.
While attempting to keeping the extracorporeal circuit
user-friendly, it is imperative that it simulates the in vivo
physiological environment as closely as possible. Thus it
was made up of two circuits in parallel, the arterial arm
being fed directly from the centrifugal pump (high pressure)
and the portal arm being fed passively from a venous
reservoir by gravity (low pressure). Efferent was retrieved
via the suprahepatic caval cannula and blood returned to the
pump, after which the blood was oxygenated and warmed.
During preservation, physiological ¯ows and pressures
were maintained in the hepatic artery, portal vein and vena
cava by controlling pump head speed and adjustment of gate
clamp resistance. At the initiation of the reperfusion phase,
the pump was maintained at a set rate (2600 cycles per
minute) so that the ¯ows and pressures within the vessels
could be used as an indication of viability.
Statistical analysis
Statistical analysis was performed using Welch's t test
(assumption of unequal variances), with each timepoint
re¯ecting the mean of four perfusions. P < 0´05 was
considered signi®cant. The comparisons were made
between the two groups for each individual parameter at
each equal timepoint in perfusion.
Results

Upon reperfusion, none of the cold-stored livers of group 1
demonstrated any sign of viability throughout the reperfusion phase. The machine-perfused livers in group 2
functioned well throughout the reperfusion phase. The
comparative data are outlined below.
Hepatocellular damage
Mean levels of alanine aminotransferase (ALAT) rose
sharply upon reperfusion in group 1 livers (Fig. 3)
compared with levels seen in group 2. This was statistically
signi®cant by 1 h of reperfusion (P = 0´016) and at all
timepoints thereafter. The rise in ALAT concentration
continued throughout reperfusion of the livers in group 1,
British Journal of Surgery 2002, 89, 609±616
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Fig. 3 Demonstration of massive hepatocellular lysis in group 1

livers with a progressive rise in alanine aminotransferase (ALAT)
levels. Values are the mean(s.e.m.) of four experiments. P < 0´05
for all timepoints (Welch's t test)

with relatively little increase seen in group 2 during the same
time period. Mimicking the ALAT curves, aspartate
aminotransferase (ASAT) levels in group 1 livers rose
rapidly to 3810 units/l after 1 h of reperfusion, whereas the
mean level of ASAT in group 2 was only 259 units/l after
1 h of reperfusion (P = 0´036). The differences between the
two groups were signi®cant at all timepoints. The mean
level of lactate dehydrogenase rose to 2985 units/l in group
1 livers by 1 h of reperfusion, compared with 1158 units/l in
group 2. The differences between the two groups continued
to grow throughout reperfusion and were statistically
signi®cant from 2 h onwards.
Synthetic function
The cold-stored livers of group 1 produced no bile after
reperfusion in any of the four perfusions. In addition, these
livers displayed haemorrhagic output from the biliary
system. The perfused livers of group 2 recovered bile
function of up to 10 ml/h. The differences were statistically
signi®cant at all timepoints (Fig. 4).
Factor V levels fell in group 1 to 12 units/dl at 24 h, while
livers in group 2 maintained synthetic function throughout
reperfusion, with a level of 263 units/dl at 24 h. The
differences were statistically signi®cant from 4 h onwards.
Metabolic function
Livers in group 1 showed no evidence of glucose consumption. Perfusate glucose levels remained above the upper
limit of detection throughout reperfusion. In contrast,
ã 2002 Blackwell Science Ltd
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Fig. 4 Group 2 livers produced bile throughout the reperfusion
phase, whereas group 1 livers made no bile. Values are the
mean(s.e.m.) of four experiments. P < 0´05 for all timepoints
(Welch's t test)

Fig. 6 Portal ¯ow deteriorates throughout reperfusion in group

1 livers, presumably due to progressive destruction of sinusoidal
and tissue architecture. Values are the mean(s.e.m.) of four
experiments. P < 0´05 for all timepoints after 10 h (Welch's t
test)

Glucose (mmol/l)

40

Group 1
Group 2

30

Both portal and arterial ¯ow followed similar curves, with
diminishing values seen in group 1. The portal ¯ow, similar
to total ¯ow, was signi®cantly greater in group 2 livers, with
a widening difference throughout reperfusion (Fig. 6).
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Fig. 5 Metabolic activity is still present after 24 h of machine
preservation as demonstrated by the glucose utilization curve for
group 2 livers. Values are the mean(s.e.m.) of four experiments.
P < 0´05 for all timepoints (Welch's t test)

group 2 livers demonstrated glucose utilization throughout
reperfusion (Fig. 5).

Despite both groups having no signi®cant difference in
haemoglobin concentration at the commencement of
reperfusion (mean(s.d.) 7´6(1´3) g/dl in group 1 versus
6´8(2´2) g/dl in group 2), the perfusate in group 1
demonstrated massive haemolysis immediately, such that
the blood gas machine could no longer detect the sample
shortly after reperfusion. A measurable level of haemoglobin was present in the 2-h sample in only one of the
experiments from this group (mean 0´98 g/dl at 2 h). By
contrast, livers in group 2 maintained measurable haemoglobin levels throughout reperfusion. The mean haemoglobin at 2 h was 5´55 g/dl (P = 0´02).
Histological ®ndings

The mean total hepatic blood ¯ow in group 1 decreased
throughout the reperfusion phase to 0´44 l/min at 24 h,
compared with 1´40 l/min at 24 h in group 2 (P = 0´005).

The group 2 livers showed diffuse, mild vacuolization and
sinusoidal dilatation with minimal to no necrosis and
preserved tissue structure. Livers in group 1 displayed
diffuse hepatocellular necrosis (more than 66 per cent per
high-power ®eld), sinusoidal haemorrhage and architectural destruction (Fig. 7).

ã 2002 Blackwell Science Ltd
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Fig. 7 a Gross hepatocellular necrosis, sinusoidal haemorrhage
and architectural destruction diffusely present. b Mild
vacuolization and sinusoidal dilatation with viable hepatocytes
and preserved tissue structure

Discussion

This experiment was based on data that oxygenated
perfusion of NHBD livers will promote cellular recovery
from warm ischaemic injury. Without perfusion, cold
storage exacerbates the injury by subjecting the organ to
additional (cold) ischaemia; then, during surgical anastomosis in the recipient, another period of warm ischaemia.
These consecutive ischaemic periods facilitate the progression of cellular injury to a state that is not compatible with
recovery upon reperfusion. It is therefore essential to
restore cellular energy levels between retrieval and reimplantation for NHBD livers.
British Journal of Surgery 2002, 89, 609±616
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Previous studies have shown that perfusion prior to
harvesting of the NHBD liver can restore cellular energy
levels before cold storage. Total body reperfusion with
cardiopulmonary bypass (CPB) using autologous blood
after 30 min without ventilation was shown to revive total
adenosine 5¢-triphosphate (ATP) content in porcine livers
and kidneys6. Conditioning the liver with 30 min of
normothermic isolated perfusion in vivo, using whole
blood, has been shown to increase mitochondrial ATP
content after 10 min of circulatory arrest in the porcine
model7. CPB for only 10 min after 30 min of arrest, at
37°C, provided functional recovery of the heart, liver and
kidney in the canine model8. In the porcine transplant
model, CPB for systemic perfusion with cold, oxygenated
Eurocollins solution restored tissue energy charge after
10 min of arrest9. These livers were then cold-stored for 5 h
and transplanted with a survival rate of 100 per cent in the
perfused group, while there were no recipient survivors in
the control group (no perfusion). The largest study utilizing
preharvest perfusion to salvage NHBD livers in the
transplant model comes from Barcelona10. In this study,
pigs were assigned progressive circulatory arrest time,
followed by CPB to perfuse the livers in vivo for 30 min
prior to cold storage and transplantation. The control
group did not undergo bypass before cold storage. The
transplant survival rate was related signi®cantly to warm
ischaemia time. However, even after 40 min of arrest, 50 per
cent survived in the perfused group, whereas there were no
survivors in the control group after only 20 min of arrest.
This work showed that bypass did regenerate tissue energy
charge, and that maintenance of these energy stores after
arrest correlated with post-transplant survival11,12.
Cellular substrates can also be restored after the NHBD
liver has been harvested. Sanguinous perfusion of isolated
porcine livers at body temperature for 3 h has been shown
to resuscitate basic liver function on a perfusion circuit after
75 min of arrest13. In this study, perfusion was initiated
immediately after harvest, representing the ®nal phase of
the experiment. This shows that sanguinous perfusion upon
retrieval does restore liver integrity after a period of warm
ischaemia. The present study con®rmed these ®ndings with
the excellent function observed in group 2 livers during the
preservation period.
Delivery of oxygen during the preservation period has
previously been shown to be successful in the NHBD model
by various methods. Persuf¯ation of oxygen during cold
storage in UW solution resulted in 100 per cent recipient
survival in an experimental group of pigs after 45 min of
arrest, while all the controls without persuf¯ation died14. In
a separate study, machine perfusion of the pig liver through
the hepatic artery with acellular perfusate (UW-gluconate)
resulted in a transplant survival rate of 80 per cent after
ã 2002 Blackwell Science Ltd
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90 min of hypotension and a brief period of arrest, while the
control group (cold storage) displayed a 25 per cent survival
rate15.
Schon et al.16 subjected porcine livers to 1 h of warm
ischaemia before harvesting, but by preserving them for 4 h
with normothermic extracorporeal perfusion using blood as
the perfusate they were able to display excellent posttransplant function in a group of six pigs. Also in this study, a
group of six pigs with the same warm ischaemia time showed
no survivors after preservation in cold UW solution for 4 h.
This work clearly delineates the bene®t of sanguinous
perfusion during preservation, but it should be noted that
the preservation period was only 4 h, which is of marginal
clinical applicability. Also, their perfusion circuit included
diaphragmatic replication and dialysis, based on previous
work17±19. In the present study excellent results were
achieved after 24 h of perfusion without these additions.
Schon's group did not provide nutrients, bile salts or
prostacyclin for their perfused livers.
In the present study normothermic perfusion was used
for an extended preservation period of 24 h. To simulate the
transplant model as closely as possible, the livers in group 1
were taken off the circuit after 24 h of machine preservation, and a 45-min period of ischaemia was initiated by
¯ushing with cold Eurocollins solution followed by warm
colloid. This subjected the livers to ischaemic periods of
cooling and rewarming before reperfusion.
The results of this experiment show, as expected, that 1 h
of warm ischaemia followed by 24 h of cold storage in UW
solution results in a completely non-viable organ. However,
24 h of normothermic perfusion preservation produces a
functioning liver, despite the same ischaemic injury. The
perfused livers in group 2 made bile, utilized glucose,
maintained stable haemodynamics and displayed histological features of viability, con®rming the hypothesis that
perfusion during the preservation period restricts the level
of ischaemic injury in the NHBD liver. These results
provide a powerful argument for the value of oxygenated
perfusion during preservation as the length of both the
arrest time and the preservation time were longer than those
in other studies. A preservation period of 24 h is much
longer than the pig liver will normally tolerate, yet the livers
in group 2 demonstrated good preservation even when this
was compounded by 60 min of arrest. Furthermore,
perfusing NHBD livers throughout the preservation period
not only replenished cellular substrate, ameliorating the
ischaemic injury, but provided a clear assessment of liver
function. This technique, in combination with the use of a
variety of viability markers, could permit the use of severely
injured organs with reassurance of function.
It is concluded that sanguinous perfusion as a method of
preservation is potentially a technically feasible means of

1 Taylor PE, Field PA, Kneteman NM. Non-heart-beating
donors: one answer to the organ shortage. Transplant Proc 1996;
28: 201.
2 Takada Y, Taniguchi H, Fukunaga K, Yuzawa K, Otsuka M,
Todoroki T et al. Hepatic allograft procurement from nonheart-beating donors: limits of warm ischemia in porcine liver
transplantation. Transplantation 1997; 63: 369±73.
3 Gomez M, Garcia-Buitron JM, Fernandez-Garcia A, Vilela D,
Fernandez-Selles C, Corbal R et al. Liver transplantation with
organs from non-heart-beating donors. Transplant Proc 1997;
29: 3478±9.
4 Casavilla A, Ramirez C, Shapiro R, Nghiem D, Miracle K,
Bronsther O et al. Experience with liver and kidney allografts
from non-heart-beating donors. Transplantation 1995; 59:
197±203.
5 D'Alessandro AM, Hoffmann RM, Knechtle SJ, Eckhoff DE,
Love RB, Kalayoglu M et al. Successful extrarenal
transplantation from non-heart-beating donors.
Transplantation 1995; 59: 977±82.
6 Arias-Diaz J, Alvarez J, Gomez M, del Barrio R, GarciaCarreras C, Gonzalez P et al. Changes in adenine nucleotides
and lipid hydroperoxides during normothermic
cardiopulmonary bypass in a porcine model of type II nonheart-beating donor. Transplant Proc 1997; 29: 3486±7.
7 Endoh T, Ohkohchi N, Katoh H, Seya K, Satomi S, Mori S et
al. Graft conditioning of liver in non-heart-beating donors by
an arti®cial heart and lung machine in situ. Transplant Proc
1996; 28: 110±15.
8 Shirakura R, Matsuda H, Nakata S, Kaneko M, Miyagawa S,
Fukushima N et al. A new method to harvest multiple organs
from non-heart-beating donors by use of a percutaneous
cardiopulmonary support machine. Transplant Proc 1992; 24:
1329±30.
9 Hoshino T, Koyama I, Nagashima N, Kadokura M, Kazui M,
Omoto R. Transplantation of livers from non-heart-beating
donors is possible by core cooling technique. Transplant Proc
1989; 21: 3519.
10 Garcia-Valdecasas JC, Tabet J, Valero R, Deulofeu R, Taura P,
Rull R et al. Evaluation of ischemic injury during liver
procurement from non-heart-beating donors. Eur Surg Res
1999; 31: 447±56.
11 Tabet J, Garcia-Valdecasas JC, Net M, Cifuentes A, Gonzalez

ã 2002 Blackwell Science Ltd

www.bjs.co.uk

providing viable organs after signi®cant warm ischaemic
injury and an extended period of preservation. The next step
in validating this technique of perfusion preservation to
salvage NHBD organs will require demonstration of
function and recovery after transplantation.
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